التداخل بين سيلوستازول وإيكوسابنت إيثيل

Increased Bleeding Risk with Anticoagulants and Antiplatelet Agents: Some published studies with omega-3 fatty acids have demonstrated prolongation of bleeding time.

Monitor patients receiving VASCEPA and concomitant anticoagulants and/or antiplatelet agents for bleeding.

Increased Bleeding Risk with Anticoagulants and Antiplatelet Agents Some published studies with omega-3 fatty acids have demonstrated prolongation of bleeding time.